{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:37:00Z","timestamp":1792089420362,"version":"4.4.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.virusres.2026.199730","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:03:52Z","timestamp":1776351832000},"page":"199730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["From legacy to innovation: A comprehensive review of vaccine platforms against viral infections"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5488-6969","authenticated-orcid":false,"given":"Niloofar","family":"Farsiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khodadadpour Mahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Arefinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Charostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Pardeshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibollah","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-2593","authenticated-orcid":false,"given":"Mohsen","family":"Nakhaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Hassandarvish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazaly","family":"AbuBakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199730_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112326","article-title":"Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination","volume":"42","author":"Adams","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.virusres.2026.199730_bib0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.53350\/pjmhs20231709261","article-title":"Recent advances in vaccine technology for viral infection management: a spotlight on next-generation vaccines and nucleic acid-based platforms","volume":"17","author":"Ali","year":"2023","journal-title":"Pakistan J. Med. Health Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0003","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-biodatasci-020722-041304","article-title":"Challenges and progress in designing broad-spectrum vaccines against rapidly mutating viruses","volume":"6","author":"Bedi","year":"2023","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0004","article-title":"Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials","volume":"34","author":"Beladiya","year":"2024","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virusres.2026.199730_bib0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/vaccines13101003","article-title":"Understanding vaccine hesitancy: insights and improvement strategies drawn from a Multi-study review","volume":"13","author":"Brumbaugh","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0006","article-title":"mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine","volume":"13","author":"Buhre","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0007","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2347019","article-title":"Pandemic preparedness through vaccine development for avian influenza viruses","volume":"20","author":"Cargnin Faccin","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.virusres.2026.199730_bib0008","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41541-025-01298-4","article-title":"A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination","volume":"10","author":"Cha","year":"2025","journal-title":"Npj Vaccin."},{"key":"10.1016\/j.virusres.2026.199730_bib0009","first-page":"1536","article-title":"Viral infections and trace elements: a complex interaction","volume":"87","author":"Chaturvedi","year":"2004","journal-title":"Curr. Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","article-title":"Current developments and challenges of mRNA vaccines","volume":"24","author":"Chen","year":"2022","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.virusres.2026.199730_bib0011","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine\u2013Induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199730_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/v16091354","article-title":"Inactivation validation of Ebola, Marburg, and Lassa viruses in AVL and ethanol-treated viral cultures","volume":"16","author":"Cutts","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0013","article-title":"Rational development of a polysaccharide\u2013Protein-conjugated nanoparticle vaccine against SARS-CoV-2 variants and Streptococcus pneumoniae","volume":"34","author":"Deng","year":"2022","journal-title":"Advanc. Mater."},{"key":"10.1016\/j.virusres.2026.199730_bib0014","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.04.021","article-title":"The challenges of vaccine development against a new virus during a pandemic","volume":"27","author":"Diamond","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virusres.2026.199730_bib0015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14760584.2018.1516552","article-title":"Virus-like particle vaccines: immunology and formulation for clinical translation","volume":"17","author":"Donaldson","year":"2018","journal-title":"Expert Rev Vacc."},{"key":"10.1016\/j.virusres.2026.199730_bib0016","first-page":"588","article-title":"Next-generation vaccine platforms: integrating synthetic biology","volume":"13","author":"Eslami","year":"2025","journal-title":"Nanotechnol. Syst. Immunol. Improved Immunogenicity. Vacc."},{"key":"10.1016\/j.virusres.2026.199730_bib0017","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1080\/17435889.2024.2416381","article-title":"Exploring potential of graphene oxide as an alternative antiviral approach for influenza A H1N1","volume":"19","author":"Farsiu","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.virusres.2026.199730_bib0018","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"N Biotechnol."},{"key":"10.1016\/j.virusres.2026.199730_bib0019","first-page":"631","article-title":"Humoral and interferon-\u03b3 immune response to DNA vaccine encoding the surface glycoprotein B of infectious laryngotracheitis virus","volume":"54","author":"Gamal","year":"2023","journal-title":"Egypt. J. Veterin. Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0020","article-title":"Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines","volume":"36","author":"Garcia-Valtanen","year":"2025","journal-title":"Molecul. Therapy Nucleic Acid."},{"key":"10.1016\/j.virusres.2026.199730_bib0021","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/vaccines9121490","article-title":"Vaccine technologies and Platforms for infectious diseases: current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0022","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev-virology-010320-044746","article-title":"Challenges of making effective influenza vaccines","volume":"7","author":"Gouma","year":"2020","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.virusres.2026.199730_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003992","article-title":"Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the alpha, delta, or omicron SARS-CoV-2 variant: a nationwide Danish cohort study","volume":"19","author":"Gram","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.virusres.2026.199730_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107586","article-title":"Mechanism of virus attenuation by codon pair deoptimization","volume":"31","author":"Groenke","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.virusres.2026.199730_bib0027","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41573-024-01041-z","article-title":"Advanced technologies for the development of infectious disease vaccines","volume":"23","author":"Gupta","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2026.199730_bib0028","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/pharmaceutics15041127","article-title":"Lipid nanoparticles as promising carriers for mRNA vaccines for viral lung infections","volume":"15","author":"Hajiaghapour Asr","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virusres.2026.199730_bib0029","article-title":"Viral infections, the microbiome, and probiotics","volume":"10","author":"Harper","year":"2020","journal-title":"Front Cell Infect. Microbiol."},{"key":"10.1016\/j.virusres.2026.199730_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ymthe.2022.09.016","article-title":"Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model","volume":"31","author":"Hawman","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2026.199730_bib0031","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.vaccine.2019.01.086","article-title":"Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production","volume":"37","author":"Herrera-Rodriguez","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199730_bib0032","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/vaccines12121345","article-title":"Vaccine strategies against RNA viruses: current advances and future directions","volume":"12","author":"Hsiung","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0033","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10120-020-01095-z","article-title":"Epstein-Barr virus-associated gastric cancer: disease that requires special approach","volume":"23","author":"Ignatova","year":"2020","journal-title":"Gastr. Cancer"},{"key":"10.1016\/j.virusres.2026.199730_bib0034","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.vaccine.2023.03.005","article-title":"Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management","volume":"41","author":"Ikewaki","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199730_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1743-422X-10-317","article-title":"Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses","volume":"10","author":"Iyer","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2026.199730_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216112","article-title":"The quest for immunity: exploring Human herpesviruses as vaccine vectors","volume":"24","author":"Kamel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0037","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1086\/380801","article-title":"Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection","volume":"189","author":"Kamili","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199730_bib0038","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.imlet.2023.05.007","article-title":"Inactivated COVID-19 vaccines: potential concerns of antibody-dependent enhancement and original antigenic sin","volume":"259","author":"Kan","year":"2023","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.virusres.2026.199730_bib0039","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1016\/j.vaccine.2014.05.053","article-title":"A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model","volume":"32","author":"Khalil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199730_bib0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/v15051109","article-title":"Virus-like particle vaccines and platforms for vaccine development","volume":"15","author":"Kheirvari","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0041","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.vaccine.2005.07.077","article-title":"Human vaccine research and development: an overview","volume":"23","author":"Kieny","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199730_bib0042","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10517-023-05970-4","article-title":"DNA vaccine encoding the artificial T-cell polyepitope immunogen of tick-borne encephalitis virus","volume":"176","author":"Kisakov","year":"2023","journal-title":"Bull Exp. Biol. Med."},{"key":"10.1016\/j.virusres.2026.199730_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.885371","article-title":"The current landscape of mRNA vaccines against viruses and cancer-a mini review","volume":"13","author":"Ladak","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.08.005","article-title":"A structure-informed atlas of Human-virus interactions","volume":"178","author":"Lasso","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199730_bib0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/v14020401","article-title":"mRNA vaccine development for emerging animal and zoonotic diseases","volume":"14","author":"Le","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0046","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee adenovirus vector Ebola vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199730_bib0047","series-title":"Chapter 23: Zoster","author":"Leung","year":"2024"},{"key":"10.1016\/j.virusres.2026.199730_bib0048","article-title":"Development of a novel assay for antigen presentation measurement","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2026.199730_bib0049","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3390\/cancers14235874","article-title":"DNA and mRNA vaccines for chronic viral infections and cancer: rationale, mechanisms, and progress","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0050","article-title":"The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0051","article-title":"Sub-neutralizing levels of antibodies against RSV F protein enhance RSV infection via fc-fc\u03b3r interactions","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0052","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1039\/D2NR06428F","article-title":"Non-viral vaccination through cationic guanidium polymer-pDNA polyplex mediated gene transfer","volume":"15","author":"Luther","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.virusres.2026.199730_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172691","article-title":"mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV","volume":"14","author":"Matarazzo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0054","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41541-021-00336-1","article-title":"Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2","volume":"6","author":"McDonald","year":"2021","journal-title":"Npj Vacc."},{"key":"10.1016\/j.virusres.2026.199730_bib0055","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2026.199730_bib0056","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/v12020138","article-title":"Smallpox in the post-eradication era","volume":"12","author":"Meyer","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0057","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0058","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8563","article-title":"Comparison of replicating and nonreplicating vaccines against SARS-CoV-2","volume":"8","author":"Mudrick","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virusres.2026.199730_bib0059","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3390\/vaccines11101535","article-title":"Long term follow-up study of a randomized, open-label, uncontrolled, phase I\/II study to assess the safety and immunogenicity of intramuscular and intradermal doses of COVID-19 DNA vaccine (AG0302-COVID19)","volume":"11","author":"Nakagami","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0060","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/vaccines11101596","article-title":"A single-dose intramuscular immunization of pigs with lipid nanoparticle DNA vaccines based on the hemagglutinin antigen confers complete protection against challenge infection with the homologous influenza virus strain","volume":"11","author":"Nguyen","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0061","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/vaccines11081372","article-title":"Plant viruses as adjuvants for next-generation vaccines and immunotherapy","volume":"11","author":"Nikitin","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0062","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/vaccines10030478","article-title":"Development of plant-based vaccines for prevention of avian influenza and Newcastle disease in poultry","volume":"10","author":"Nurzijah","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0063","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/vaccines10020138","article-title":"Plant-based vaccines in combat against coronavirus diseases","volume":"10","author":"Ortega-Berlanga","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA vaccines: history, molecular mechanisms and future perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virusres.2026.199730_bib0065","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1021\/acsnano.3c01829","article-title":"An intranasal multivalent epitope-based nanoparticle vaccine confers broad protection against divergent influenza viruses","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.virusres.2026.199730_bib0066","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/vaccines13090989","article-title":"Advances in biotechnology and the development of novel Human vaccines","volume":"13","author":"Papadatou","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0067","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202249941","article-title":"Nonreplicating synthetic mRNA vaccines: a journey through the European (Journal of Immunology) history","volume":"53","author":"Pascolo","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0068","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/infdis\/jiad235","article-title":"Safety and immunogenicity of an andes virus DNA vaccine by needle-free injection: a randomized, controlled phase 1 study","volume":"229","author":"Paulsen","year":"2024","journal-title":"J. Infect Dis."},{"key":"10.1016\/j.virusres.2026.199730_bib0069","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00704-20","article-title":"Structure-based design of Hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization","volume":"94","author":"Pierce","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199730_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0071","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2026.199730_bib0072","doi-asserted-by":"crossref","DOI":"10.1097\/IPC.0000000000001433","article-title":"Evaluating the role of COVID-19 vaccines in patient outcomes: evidence from the eighth wave in Kerman, Iran","volume":"33","author":"Raisi Sarbijan","year":"2025","journal-title":"Infect Dis Clin. Pract."},{"key":"10.1016\/j.virusres.2026.199730_bib0073","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199730_bib0074","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2019.10.045","article-title":"Recent advances on HIV DNA vaccines development: stepwise improvements to clinical trials","volume":"316","author":"Rezaei","year":"2019","journal-title":"J. Control. Release."},{"key":"10.1016\/j.virusres.2026.199730_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28572","article-title":"mRNA vaccines: the future of prevention of viral infections?","volume":"95","author":"Rzymski","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2026.199730_bib0076","doi-asserted-by":"crossref","first-page":"35","DOI":"10.9734\/ajbgmb\/2022\/v12i130285","article-title":"An extensive review on the development of plant-based vaccines against SARS-Cov-2 and Respiratory disorders using plant biotechnology platform","author":"Samanta","year":"2022","journal-title":"AJBGMB"},{"key":"10.1016\/j.virusres.2026.199730_bib0077","first-page":"45","article-title":"Inactivated viral vaccines","author":"Sanders","year":"2014","journal-title":"Vacc. Anal."},{"key":"10.1016\/j.virusres.2026.199730_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101430","article-title":"New viral vectors for infectious diseases and cancer","volume":"50","author":"Sasso","year":"2020","journal-title":"Semin Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572681","article-title":"Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine","volume":"10","author":"Shukla","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virusres.2026.199730_bib0080","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","article-title":"Drug combination therapy for emerging viral diseases","volume":"26","author":"Shyr","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.virusres.2026.199730_bib0081","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2014.02.080","article-title":"Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of vaccinia-HCV virus infection: a dose and route conundrum","volume":"32","author":"Singh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2026.199730_bib0082","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection","volume":"20","author":"Slon-Campos","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0083","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection","volume":"20","author":"Slon-Campos","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0084","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.12.11.24","article-title":"Safety and efficacy of adeno-associated viral gene therapy in patients with retinal degeneration: a systematic review and meta-analysis","volume":"12","author":"Sobh","year":"2023","journal-title":"Trans. Vis. Sci. Tech."},{"key":"10.1016\/j.virusres.2026.199730_bib0085","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/vaccines11050965","article-title":"A plant-derived maternal vaccine against porcine epidemic diarrhea protects piglets through maternally derived immunity","volume":"11","author":"Sohn","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1012844","article-title":"Key virulence factors responsible for differences in pathogenicity between clinically proven live-attenuated Japanese encephalitis vaccine SA14-14-2 and its pre-attenuated highly virulent parent SA14","volume":"21","author":"Song","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2026.199730_bib0087","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/vaccines11081287","article-title":"Just keep rolling?\u2014an encompassing review towards accelerated vaccine product life cycles","volume":"11","author":"Stiefel","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2023.1170815","article-title":"Plant-made vaccines against viral diseases in humans and farm animals","volume":"14","author":"Su","year":"2023","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.virusres.2026.199730_bib0089","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/vaccines11020197","article-title":"Antibody-dependent enhancement activity of a plant-made vaccine against west nile virus","volume":"11","author":"Sun","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virusres.2026.199730_bib0090","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/vaccines13050532","article-title":"Development of new live-attenuated vaccine candidates lacking antibody-dependent enhancement (ADE) against dengue","volume":"13","author":"Tan","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.virusres.2026.199730_bib0091","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1469-0691.12536","article-title":"The rediscovery of smallpox","volume":"20","author":"Th\u00e8ves","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.virusres.2026.199730_bib0092","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2505356","article-title":"Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination","volume":"21","author":"Thomas","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.virusres.2026.199730_bib0093","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1008684","article-title":"mRNA vaccines: a novel weapon to control infectious diseases","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2026.199730_bib0094","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3390\/v15122378","article-title":"Evolving horizons: adenovirus vectors\u2019 Timeless influence on cancer, gene therapy and vaccines","volume":"15","author":"Trivedi","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0095","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2020.02130","article-title":"Viral emerging diseases: challenges in developing vaccination strategies","volume":"11","author":"Trovato","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.virusres.2026.199730_bib0096","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1880","article-title":"Gene-encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity","volume":"15","author":"Tursi","year":"2023","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.virusres.2026.199730_bib0097","first-page":"627","article-title":"Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer","volume":"9","author":"Ullas","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.virusres.2026.199730_bib0098","first-page":"284","article-title":"Viral Respiratory infections","author":"Van Doorn","year":"2020","journal-title":"Hunter\u2019s Tropic. Med. Emerg. Infect. Dis."},{"key":"10.1016\/j.virusres.2026.199730_bib0099","doi-asserted-by":"crossref","first-page":"328","DOI":"10.53854\/liim-2903-3","article-title":"Review of COVID-19 viral vector-based vaccines and COVID-19 variants","volume":"29","author":"Vanaparthy","year":"2021","journal-title":"Infez Med."},{"key":"10.1016\/j.virusres.2026.199730_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41541-023-00737-4","article-title":"Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines","volume":"8","author":"Vinz\u00f3n","year":"2023","journal-title":"NPJ Vacc."},{"key":"10.1016\/j.virusres.2026.199730_bib0101","article-title":"Subunit vaccines against emerging pathogenic Human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virusres.2026.199730_bib0102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41392-024-01917-x","article-title":"Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control","volume":"9","author":"Wang","year":"2024","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.virusres.2026.199730_bib0103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Sig Transduct Target Ther."},{"key":"10.1016\/j.virusres.2026.199730_bib0104","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00689-25","article-title":"Design of antibody structure-guided epitope vaccines in silico to induce potent immune responses against emerging viruses","volume":"99","author":"Wei","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199730_bib0108","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00705-021-04959-6","article-title":"Viral infections and their relationship to neurological disorders","volume":"166","author":"Wouk","year":"2021","journal-title":"Arch Virol."},{"key":"10.1016\/j.virusres.2026.199730_bib0109","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1857","article-title":"Nanovaccines to combat virus-related diseases","volume":"15","author":"Wu","year":"2023","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.virusres.2026.199730_bib0110","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1039\/D4NR00019F","article-title":"Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines","volume":"16","author":"Wu","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.virusres.2026.199730_bib0111","series-title":"Animal Biotechnology","first-page":"491","article-title":"Vaccines","author":"Yadav","year":"2014"},{"key":"10.1016\/j.virusres.2026.199730_bib0112","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/pharmaceutics15031009","article-title":"DLin-MC3-containing mRNA lipid nanoparticles induce an antibody Th2-biased immune response polarization in a delivery route-dependent manner in mice","volume":"15","author":"Yavuz","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virusres.2026.199730_bib0113","doi-asserted-by":"crossref","first-page":"15231","DOI":"10.1021\/acsnano.2c12584","article-title":"The mRNA vaccine revolution: COVID-19 has launched the future of vaccinology","volume":"17","author":"Ye","year":"2023","journal-title":"ACS Nano."},{"key":"10.1016\/j.virusres.2026.199730_bib0114","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/life12020156","article-title":"Plant-derived recombinant vaccines against zoonotic viruses","volume":"12","author":"Zahmanova","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.virusres.2026.199730_bib0115","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/v15102043","article-title":"Exploring the potential of cytomegalovirus-based vectors: a review","volume":"15","author":"Zeng","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0116","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2023-0018","article-title":"Nanoparticle-based vaccines against zoonotic viruses: a review","volume":"3","author":"Zhang","year":"2023","journal-title":"Zoonoses"},{"key":"10.1016\/j.virusres.2026.199730_bib0117","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/v15091873","article-title":"DNA vaccine Co-expressing hemagglutinin and IFN-\u03b3 provides partial protection to ferrets against lethal challenge with canine distemper virus","volume":"15","author":"Zhao","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0118","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/v15081760","article-title":"Vaccines\u2019 NEW era-RNA vaccine","volume":"15","author":"Zhou","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2026.199730_bib0119","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-022-30340-5","article-title":"Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant","volume":"13","author":"Zuo","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:16:15Z","timestamp":1780139775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":116,"alternative-id":["S0168170226000493"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199730","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From legacy to innovation: A comprehensive review of vaccine platforms against viral infections","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199730"}}